Skip to main content

Table 1 Baseline and treatment characteristics of the enrolled patients (data shown as median IQR)

From: Safety and efficacy of the Seraph® 100 Microbind® Affinity Blood Filter to remove bacteria from the blood stream: results of the first in human study

Sex (F/M)

Age (years)

BMI (kg)

Dialysis vintage (months)

Blood flow (ml/min)

Dialysate flow (ml/min)

Ultrafiltration volume (ml)

Time enrolment to treatment (h)

Pathogen

F

72

42.5

86

250

250

0

89.25

Staph. aureus

M

74

24.0

39

285

500

1000

138.75

E. coli

M

69

24.3

15

81

81

0

45.0

Staph. aureus

M

57

33.3

28

300

500

2500

70.47

Staph. aureus

M

82

26.3

3

300

500

1600

66.4

Staph. aureus

M

67

27.2

29

300

500

3500

86.12

Staph. aureus

M

81

13.7

7

300

500

400

46.45

Staph. epidermidis

M

78

23.9

3

300

500

600

65.39

Staph. aureus

M

51

37.9

0.75

300

500

600

44.23

E. faecalis

F

75

36.0

75

250

500

3200

75.14

Staph. epidermidis

M

79

20.7

202

150

500

-1500

65.35

Staph. aureus

F

89

25.6

28

300

500

1300

99.25

Staph. aureus

M

70

33.1

51

250

250

320

23.5

E. faecalis

M

66

16.2

38

150

500

-1500

40.5

Klebsiella pneumoniae

M

78

28.0

20

200

500

1000

72.25

Staph. aureus

3/12

74.0

[68.0–78.5]

26.3

[24.0–33.2]

28.0

[11.0–45.0]

285

[225–300]

500

[500–500]

600

[160–1450]

66.4

[45.7–80.6]